Board Meetings for SMSPHARMA
Detailed list of historic and upcoming board meetings.
| Symbol | Company | Meeting Date | Purpose | Description | Links |
|---|---|---|---|---|---|
| SMSPHARMA | SMS Pharmaceuticals Limited | 22 May 2026 | Financial Results/Dividend/Other business matters | To consider and approve the financial results for the period ended March 31, 2026, dividend and other business matters | |
| SMSPHARMA | SMS Pharmaceuticals Limited | 22 May 2026 | Board Meeting Intimation | SMS PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 22-May-2026 to consider and approve the Yearly Audited Financial results of the Company for the period ended March 2026 and Dividend/Other business. | |
| SMSPHARMA | SMS Pharmaceuticals Limited | 07 Feb 2026 | Financial Results/Other business matters | To consider and approve the financial results for the period ended December 31, 2025 and other business matters | |
| SMSPHARMA | SMS Pharmaceuticals Limited | 07 Feb 2026 | Board Meeting Intimation | SMS PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 07-Feb-2026 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended December 2025 and Other business. | |
| SMSPHARMA | SMS Pharmaceuticals Limited | 08 Nov 2025 | Board Meeting Intimation | SMS PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 08-Nov-2025 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended September 2025 and Other business. | |
| SMSPHARMA | SMS Pharmaceuticals Limited | 08 Nov 2025 | Financial Results/Other business matters | To consider and approve the financial results for the period ended September 30, 2025 and other business matters | |
| SMSPHARMA | SMS Pharmaceuticals Limited | 09 Aug 2025 | Financial Results/Other business matters | To consider and approve the financial results for the period ended Jun 30, 2025 and other business matters | |
| SMSPHARMA | SMS Pharmaceuticals Limited | 09 Aug 2025 | Board Meeting Intimation | SMS PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 09-Aug-2025 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended June 2025 and Other business. | |
| SMSPHARMA | SMS Pharmaceuticals Limited | 30 May 2025 | Financial Results/Dividend/Other business matters | To consider and approve the financial results for the period ended March 31, 2025, dividend and other business matters | |
| SMSPHARMA | SMS Pharmaceuticals Limited | 30 May 2025 | Board Meeting Intimation | SMS PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 30-May-2025 to consider and approve the Yearly Audited Financial results of the Company for the period ended March 2025 and Dividend/Other business. | |
| SMSPHARMA | SMS Pharmaceuticals Limited | 12 Feb 2025 | Financial Results/Other business matters | To consider and approve the financial results for the period ended December 31, 2024 and other business matters | |
| SMSPHARMA | SMS Pharmaceuticals Limited | 12 Feb 2025 | Board Meeting Intimation | SMS PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 12-Feb-2025 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended December 2024 and Other business. | |
| SMSPHARMA | SMS Pharmaceuticals Limited | 08 Nov 2024 | Financial Results/Other business matters | To consider and approve the financial results for the period ended September 30, 2024 and other business matters | |
| SMSPHARMA | SMS Pharmaceuticals Limited | 08 Nov 2024 | Board Meeting Intimation | SMS PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 08-Nov-2024 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended September 2024 and Other business. | |
| SMSPHARMA | SMS Pharmaceuticals Limited | 05 Aug 2024 | Financial Results/Other business matters | To consider and approve the financial results for the period ended Jun 30, 2024 and other business matters |
Showing page 1 of 8 (107 total items)